CRISPR Therapeutics AG (CRSP)

53.46 -1.18 (-2.16%) USD  |  NASDAQ  |  Feb 20, 16:00
52.52 -0.94 (-1.76%) Pre-Market: 08:21
More

CRISPR Therapeutics Sell Recommendations

Sell Recommendations Chart

View Sell Recommendations for CRSP.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Sell Recommendations Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Sell Recommendations Range, Past 5 Years

View Sell Recommendations Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Sell Recommendations Benchmarks

View Sell Recommendations Benchmarks
Start Trial
Vertex Pharmaceuticals, Inc. Upgrade
Beam Therapeutics, Inc. Upgrade
Novartis AG Upgrade
Recursion Pharmaceuticals, Inc. Upgrade
EvoNext Holdings SA --